DK672789D0 - Nukleinsyresekvens samt rekombinant vaertscelle transformeret med samme - Google Patents

Nukleinsyresekvens samt rekombinant vaertscelle transformeret med samme

Info

Publication number
DK672789D0
DK672789D0 DK672789A DK672789A DK672789D0 DK 672789 D0 DK672789 D0 DK 672789D0 DK 672789 A DK672789 A DK 672789A DK 672789 A DK672789 A DK 672789A DK 672789 D0 DK672789 D0 DK 672789D0
Authority
DK
Denmark
Prior art keywords
nucleic acid
fipv
recombinant
acid sequence
same
Prior art date
Application number
DK672789A
Other languages
English (en)
Other versions
DK174187B1 (da
DK672789A (da
Inventor
Beverly Dale
Miles Yamanaka
William N Acree
Jr Lloyd G Chavez
Original Assignee
California Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Biotechnology Inc filed Critical California Biotechnology Inc
Publication of DK672789D0 publication Critical patent/DK672789D0/da
Publication of DK672789A publication Critical patent/DK672789A/da
Application granted granted Critical
Publication of DK174187B1 publication Critical patent/DK174187B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/102—Coronaviridae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK198906727A 1988-12-30 1989-12-29 Rekombinant ekspressionssystem omfattende en nukleinsyresekvens, der koder for E1- eller N-proteinet af felin infektiøs peritonitis virus (FIPV), rekombinant ekspressionsvektor omfattende ekspressionssystemet, rekombinante værtsceller DK174187B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29252788A 1988-12-30 1988-12-30
US29252788 1988-12-30

Publications (3)

Publication Number Publication Date
DK672789D0 true DK672789D0 (da) 1989-12-29
DK672789A DK672789A (da) 1990-07-01
DK174187B1 DK174187B1 (da) 2002-08-26

Family

ID=23125039

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198906727A DK174187B1 (da) 1988-12-30 1989-12-29 Rekombinant ekspressionssystem omfattende en nukleinsyresekvens, der koder for E1- eller N-proteinet af felin infektiøs peritonitis virus (FIPV), rekombinant ekspressionsvektor omfattende ekspressionssystemet, rekombinante værtsceller

Country Status (12)

Country Link
US (2) US5780266A (da)
EP (1) EP0376744B1 (da)
JP (1) JP2903129B2 (da)
AT (1) ATE126537T1 (da)
AU (1) AU640356B2 (da)
CA (1) CA2005291C (da)
DE (1) DE68923862T2 (da)
DK (1) DK174187B1 (da)
ES (1) ES2078246T3 (da)
GR (1) GR3017770T3 (da)
IE (1) IE67650B1 (da)
NZ (1) NZ231850A (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
CA2020740A1 (en) * 1989-07-12 1991-01-13 Harry Vennema Antigenically active proteins/peptides, and feline infectious peritonitis virus (fipv)-vaccines
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
NZ240558A (en) * 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
ES2213743T3 (es) * 1991-04-25 2004-09-01 Akzo Nobel N.V. Vacuna de subunidad de coronavirus canino.
EP0524672A1 (en) * 1991-06-27 1993-01-27 Duphar International Research B.V CCV vaccine
CA2128698A1 (en) * 1992-02-18 1993-08-19 Richard G. Olsen Feline infectious peritonitis vaccine and method of preparation
JP3245169B2 (ja) * 1992-05-08 2002-01-07 ファイザー・インコーポレイテッド イヌ・コロナウイルスｓ遺伝子およびその使用
WO1993023421A1 (en) * 1992-05-08 1993-11-25 Smithkline Beecham Corporation Universal coronavirus vaccine
GB2316681B (en) * 1993-09-16 1998-04-15 Dimminaco Ag Sa Ltd Antigenically active proteins/polypeptides and coronavirus vaccines containing the same
TW377373B (en) * 1993-09-22 1999-12-21 Wyeth Corp Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
US5858373A (en) * 1995-12-01 1999-01-12 Virogenetics Corporation Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them
AU5530498A (en) * 1996-12-18 1998-07-15 Synbiotics Corporation A specific diagnostic for antibodies to feline infectious peritonitis virus
US7255986B2 (en) * 2002-01-31 2007-08-14 The Board Of Trustees Operating Michigan State University Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets
JP4242607B2 (ja) * 2002-07-04 2009-03-25 学校法人北里研究所 ネコ伝染性腹膜炎ワクチン
RU2236678C2 (ru) * 2002-11-04 2004-09-20 Красноярская государственная медицинская академия Способ прогноза исхода перитонита средней степени тяжести по содержанию некоторых жирных кислот в лимфоцитах больных
AU2004269320B2 (en) 2003-06-20 2009-12-24 Protein Sciences Corporation Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
RU2480756C2 (ru) * 2011-02-10 2013-04-27 Государственное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Способ прогнозирования течения послеоперационного периода у больных с перитонитом
US10801070B2 (en) 2013-11-25 2020-10-13 The Broad Institute, Inc. Compositions and methods for diagnosing, evaluating and treating cancer
US11725237B2 (en) 2013-12-05 2023-08-15 The Broad Institute Inc. Polymorphic gene typing and somatic change detection using sequencing data
NZ721908A (en) 2013-12-20 2022-12-23 Massachusetts Gen Hospital Combination therapy with neoantigen vaccine
EP4636401A2 (en) 2014-12-19 2025-10-22 The Broad Institute, Inc. Methods for profiling the t-cell-receptor repertoire
US10975442B2 (en) 2014-12-19 2021-04-13 Massachusetts Institute Of Technology Molecular biomarkers for cancer immunotherapy
CA2986235A1 (en) 2015-05-20 2016-11-24 The Broad Institute, Inc. Shared neoantigens
TWI750122B (zh) 2015-06-09 2021-12-21 美商博德研究所有限公司 用於贅瘤疫苗之調配物及其製備方法
AU2017254477A1 (en) 2016-04-18 2018-11-01 Jennifer G. ABELIN Improved HLA epitope prediction
US11549149B2 (en) 2017-01-24 2023-01-10 The Broad Institute, Inc. Compositions and methods for detecting a mutant variant of a polynucleotide
US20220062394A1 (en) 2018-12-17 2022-03-03 The Broad Institute, Inc. Methods for identifying neoantigens
US12394502B2 (en) 2019-10-02 2025-08-19 The General Hospital Corporation Method for predicting HLA-binding peptides using protein structural features

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5576820A (en) * 1978-11-30 1980-06-10 Wellcome Found Feline infectious peritonitis vaccine
AU5329279A (en) * 1978-11-30 1980-06-05 Wellcome Foundation Limited, The Feline infectious peritonitis vaccine
US4293653A (en) * 1979-04-12 1981-10-06 Horzinek Marian C Method for propagating feline infectious peritonitis virus
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
JPS63502828A (ja) * 1986-02-06 1988-10-20 コーネル・リサーチ・ファウンデーション、インコーポレイテッド ネコ感染性腹膜炎ワクチン
EP0264979A1 (en) * 1986-09-05 1988-04-27 Duphar International Research B.V New antigenically active proteins and peptides, and feline infectious peritonitis virus (FIPV) vaccines
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
CA2011025A1 (en) * 1989-03-01 1990-09-01 Terry R. Beardsley Feline infectious peritonitis vaccine
CA2020740A1 (en) * 1989-07-12 1991-01-13 Harry Vennema Antigenically active proteins/peptides, and feline infectious peritonitis virus (fipv)-vaccines
US5202430A (en) * 1990-01-16 1993-04-13 University Of Tennessee Transmissible gastroenteritis virus genes

Also Published As

Publication number Publication date
DE68923862D1 (de) 1995-09-21
US5811104A (en) 1998-09-22
JPH02291273A (ja) 1990-12-03
ES2078246T3 (es) 1995-12-16
DE68923862T2 (de) 1996-02-08
CA2005291A1 (en) 1990-06-30
US5780266A (en) 1998-07-14
AU4691589A (en) 1990-07-05
GR3017770T3 (en) 1996-01-31
ATE126537T1 (de) 1995-09-15
DK174187B1 (da) 2002-08-26
IE894222L (en) 1990-06-30
EP0376744A1 (en) 1990-07-04
DK672789A (da) 1990-07-01
IE67650B1 (en) 1996-04-17
JP2903129B2 (ja) 1999-06-07
EP0376744B1 (en) 1995-08-16
AU640356B2 (en) 1993-08-26
CA2005291C (en) 1999-01-26
NZ231850A (en) 1992-10-28

Similar Documents

Publication Publication Date Title
DK672789A (da) Nukleinsyresekvens samt rekombinant vaertscelle transformeret med samme
UA42668C2 (uk) Поліпептид, що має антигенні властивості вірусу гепатиту с (hcv) (варіанти), діагностичний реагент для виявлення антитіл до вірусу гепатиту с (варіанти), набір для виявлення антитіл до вірусу гепатиту с (варіанти), спосіб виявлення антитіл до вірусу гепатиту с (варіанти)
ATE366314T1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
FI946066A0 (fi) Hepatiitti-C viruksen genotyyppien uudet sekvenssit ja niiden käyttö terapeuttisina ja diagnostisina aineina
NL300137I1 (nl) Recombinante proteïnen van virussen geassocieerd met het
DK0644202T3 (da) Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
DK645887A (da) Gamma-hesteinterferon, fremgangsmaade til fremstilling af, samt anvendelse af en saadan forbindelse
DK157186A (da) Ekspression af immunologisk aktive virale proteiner
DK482788A (da) Vacciner mod og diagnostiske bestemmelser af haemophilus influenzae
ES2133269T3 (es) Gen receptor del factor de crecimiento derivado de plaquetas de tipo oc.
ATE82985T1 (de) Strukturelles phosphoprotein (pp 150) des menschlichen cytomegalovirus, seine herstellung und verwendung.
NO175153C (no) Polypeptider
ATE124420T1 (de) Impfstoffe und testsätze für haemophilus influenzae.
DE60029327D1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
ATE136933T1 (de) Rekombinante hbsag hybridpartikel, die morphologische eigenschaften von hbsag-antigen haben und eine immunogene sequenz enthalten, die neutralisierende antikörper gegen hiv induziert oder die von diesen antikörpern erkannt ist, nukleotide sequenzen, die diese partikel codieren und sie enthaltende impfstoffe
ATE115964T1 (de) Non-a non-b sequenzen.
DK204588D0 (da) Humane rhinoviruspeptider, fremgangsmaade til deres fremstilling samt vacciner med inhold af saadanne peptider

Legal Events

Date Code Title Description
PUP Patent expired